Universal cervical length screening and treatment with vaginal progesterone to prevent preterm birth: a decision and economic analysis

American Journal of Obstetrics and Gynecology

Volumn 202, Issue 6, 2010, Pages 548.e1-548.e8

  Cahill, Alison G ^a   Odibo, Anthony O ^a   Caughey, Aaron B ^b   Stamilio, David M ^a   Hassan, Sonia S ^c,d   Macones, George A ^a   Romero, Roberto ^c,e  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^d HUTZEL HOSPITAL   (United States)

^e WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

cervical length screening; preterm birth; prevention; progesterone

Indexed keywords

HYDROXYPROGESTERONE CAPROATE;

ARTICLE; CERVICAL LENGTH MEASUREMENT; CONTROLLED STUDY; COST CONTROL; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; HIGH RISK POPULATION; NEWBORN DEATH; NEWBORN MORBIDITY; NEWBORN MORTALITY; PREGNANCY OUTCOME; PREMATURE LABOR; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; TRANSVAGINAL ECHOGRAPHY; UNITED STATES;

EID: 77952883807     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2009.12.005     Document Type: Article

References (36)

1. Mathews T.J., Curtin S.C., and MacDorman M.F. Infant mortality statistics from the 1998 period linked birth/infant death data set. Natl Vital Stat Rep 48 (2000) 1-25
2. Carey J.C., Klebanoff M.A., Hauth J.C., et al. Metronidazole to prevent preterm delivery in pregnant women with asymptomatic bacterial vaginosis: National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. N Engl J Med 342 (2000) 534-540
3. Dyson D.C., Crites Y.M., Ray D.A., and Armstrong M.A. Prevention of preterm birth in high-risk patients: the role of education and provider contact versus home uterine monitoring. Am J Obstet Gynecol 164 (1991) 756-762
4. Goldenberg R.L., Iams J.D., Das A., et al. The Preterm Prediction Study: sequential cervical length and fetal fibronectin testing for the prediction of spontaneous preterm birth: National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Am J Obstet Gynecol 182 (2000) 636-643
5. Goldenberg R.L., Iams J.D., Mercer B.M., et al. The preterm prediction study: the value of new vs standard risk factors in predicting early and all spontaneous preterm births: National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Am J Public Health 88 (1998) 233-238
6. Goldenberg R.L., Iams J.D., Miodovnik M., et al. The preterm prediction study: risk factors in twin gestations: National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Am J Obstet Gynecol 175 (1996) 1047-1053
7. Goldenberg R.L., Mercer B.M., Meis P.J., Copper R.L., Das A., and McNellis D. The preterm prediction study: fetal fibronectin testing and spontaneous preterm birth: National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Obstet Gynecol 87 (1996) 643-648
8. Hauth J.C., Goldenberg R.L., Andrews W.W., DuBard M.B., and Copper R.L. Reduced incidence of preterm delivery with metronidazole and erythromycin in women with bacterial vaginosis. N Engl J Med 333 (1995) 1732-1736
9. Iams J.D., Goldenberg R.L., Meis P.J., et al. The length of the cervix and the risk of spontaneous premature delivery: National Institute of Child Health and Human Development Maternal Fetal Medicine Unit Network. N Engl J Med 334 (1996) 567-572
10. Iams J.D., Goldenberg R.L., Mercer B.M., et al. The Preterm Prediction Study: recurrence risk of spontaneous preterm birth: National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Am J Obstet Gynecol 178 (1998) 1035-1040
11. Iams J.D., Johnson F.F., and O'Shaughnessy R.W. A prospective random trial of home uterine activity monitoring in pregnancies at increased risk of preterm labor, part II. Am J Obstet Gynecol 159 (1988) 595-603
12. Lockwood C.J., Senyei A.E., Dische M.R., et al. Fetal fibronectin in cervical and vaginal secretions as a predictor of preterm delivery. N Engl J Med 325 (1991) 669-674
13. Mercer B.M., Goldenberg R.L., Das A., et al. The preterm prediction study: a clinical risk assessment system. Am J Obstet Gynecol 174 (1996) 1885-1895
14. Fonseca E.B., Celik E., Parra M., Singh M., and Nicolaides K.H. Progesterone and the risk of preterm birth among women with a short cervix. N Engl J Med 357 (2007) 462-469
15. DeFranco E.A., O'Brien J.M., Adair C.D., et al. Vaginal progesterone is associated with a decrease in risk for early preterm birth and improved neonatal outcome in women with a short cervix: a secondary analysis from a randomized, double-blind, placebo-controlled trial. Ultrasound Obstet Gynecol 30 (2007) 697-705
16. Medicare: US Department of Health and Human Services. National limitations: clinical lab (1995), US Department of Health and Human Services, Washington, DC
17. Drummond M.F., Sculpher M.J., Torrance G.W., O'Brien B.J., and Stoddart G.L. Methods for the economic evaluation of health care programmes (2005), Oxford University Press, New York
18. Meis P.J., Klebanoff M., Thom E., et al. Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate. N Engl J Med 348 (2003) 2379-2385
19. O'Brien J.M., Adair C.D., Lewis D.F., et al. Progesterone vaginal gel for the reduction of recurrent preterm birth: primary results from a randomized, double-blind, placebo-controlled trial. Ultrasound Obstet Gynecol 30 (2007) 687-696
20. Rouse D.J., Caritis S.N., Peaceman A.M., et al. A trial of 17 alpha-hydroxyprogesterone caproate to prevent prematurity in twins. N Engl J Med 357 (2007) 454-461
21. American College of Obstetricians and Gynecologists. Use of progesterone to reduce preterm birth: ACOG committee opinion no. 419. Obstet Gynecol 112 (2008) 963-965
22. Romero R. Prevention of spontaneous preterm birth: the role of sonographic cervical length in identifying patients who may benefit from progesterone treatment. Ultrasound Obstet Gynecol 30 (2007) 675-686
23. Celik E., To M., Gajewska K., Smith G.C., and Nicolaides K.H. Cervical length and obstetric history predict spontaneous preterm birth: development and validation of a model to provide individualized risk assessment. Ultrasound Obstet Gynecol 31 (2008) 549-554
24. Heath V.C., Souka A.P., Erasmus I., Gibb D.M., and Nicolaides K.H. Cervical length at 23 weeks of gestation: the value of Shirodkar suture for the short cervix. Ultrasound Obstet Gynecol 12 (1998) 318-322
25. Hibbard J.U., Tart M., and Moawad A.H. Cervical length at 16-22 weeks' gestation and risk for preterm delivery. Obstet Gynecol 96 (2000) 972-978
26. To M.S., Alfirevic Z., Heath V.C., et al. Cervical cerclage for prevention of preterm delivery in women with short cervix: randomised controlled trial. Lancet 363 (2004) 1849-1853
27. Hassan S.S., Romero R., Berry S.M., et al. Patients with an ultrasonographic cervical length ≤15 mm have nearly a 50% risk of early spontaneous preterm delivery. Am J Obstet Gynecol 182 (2000) 1458-1467
28. Mercer B.M., Goldenberg R.L., Moawad A.H., et al. The preterm prediction study: effect of gestational age and cause of preterm birth on subsequent obstetric outcome: National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Am J Obstet Gynecol 181 (1999) 1216-1221
29. Petrini J.R., Callaghan W.M., Klebanoff M., et al. Estimated effect of 17 alpha-hydroxyprogesterone caproate on preterm birth in the United States. Obstet Gynecol 105 (2005) 267-272
30. Martin J.A., Hamilton B.E., Sutton P.D., et al. Births: final data for 2005. Natl Vital Stat Rep 56 (2007) 1-103
31. Stoelhorst G.M., Rijken M., Martens S.E., et al. Changes in neonatology: comparison of two cohorts of very preterm infants (gestational age <32 weeks): the Project on Preterm and Small for Gestational Age Infants 1983 and the Leiden Follow-Up Project on Prematurity 1996-1997. Pediatrics 115 (2005) 396-405
32. Zeitlin J., Draper E.S., Kollee L., et al. Differences in rates and short-term outcome of live births before 32 weeks of gestation in Europe in 2003: results from the MOSAIC cohort. Pediatrics 121 (2008) e936-e944
33. McIntire D.D., and Leveno K.J. Neonatal mortality and morbidity rates in late preterm births compared with births at term. Obstet Gynecol 111 (2008) 35-41
34. Vandenbussche F.P., De Jong-Potjer L.C., Stiggelbout A.M., Le Cessie S., and Keirse M.J. Differences in the valuation of birth outcomes among pregnant women, mothers, and obstetricians. Birth 26 (1999) 178-183
35. Pham C.T., and Crowther C.A. Birth outcomes: utility values that postnatal women, midwives and medical staff express. BJOG 110 (2003) 121-127
36. Waitzman N.J., Romano P.S., and Scheffler R.M. Estimates of the economic costs of birth defects. Inquiry 31 (1994) 188-205